B12 (1ml diluted – 10ml vial)

LIPO-C w/o B12 combines multiple agents commonly grouped under the “lipotropic” and metabolic cofactor category:

• Methionine (15 mg/mL): A sulfur-containing essential amino acid and methyl-group donor involved in S-adenosylmethionine (SAM)–dependent methylation reactions.
• Choline Chloride (50 mg/mL): A key precursor for phosphatidylcholine synthesis and a critical factor in very-low-density lipoprotein (VLDL) assembly and membrane integrity in hepatocyte models.
• L-Carnitine (50 mg/mL): A transporter-like molecule supporting mitochondrial uptake of long-chain fatty acids via the carnitine shuttle in cellular bioenergetics studies.
• Dexpanthenol (5 mg/mL): A provitamin B5 derivative that participates in coenzyme A (CoA)–related metabolic pathways.

Supplied in 10 mL and 30 mL multidose vials, LIPO-C w/o B12 is designed to allow flexible dosing schemes for in vitro and in vivo experimental designs, where investigators can adjust exposure parameters to evaluate combined or individual biochemical effects.

Lipotropic Components and Hepatic Lipid Handling
Lipotropic compounds such as choline- and inositol-based molecules are widely used in experimental designs to investigate:

• VLDL Assembly and Export: Choline-dependent phosphatidylcholine synthesis is central to very-low-density lipoprotein (VLDL) formation, which is a primary route for lipid export from hepatocytes. Lipotropic combinations are often used to probe how substrate availability affects this process in cell or animal models.
• Triglyceride Accumulation: Models of hepatic steatosis (fat accumulation in the liver) may include lipotropic agents to evaluate whether modulating phospholipid and methyl donors alters lipid droplet behavior or hepatic fat content markers.
• Bile and Phospholipid Balance: Because phospholipids are critical constituents of bile, research may study lipotropic blends to understand how altered phospholipid supply influences bile composition, hepatocyte membrane integrity, and related endpoints.

These lines of investigation are strictly mechanistic and do not establish clinical “fat-burning” or detoxification claims.

Vitamin B12 and One-Carbon Metabolism
Vitamin B12 (cobalamin) is an essential cofactor for several enzymes involved in one-carbon metabolism and energy-related pathways:

• Methionine Synthase: B12-dependent remethylation of homocysteine to methionine is central to the generation of S-adenosylmethionine (SAM), a universal methyl donor used in DNA, protein, and phospholipid methylation.
• Methylmalonyl-CoA Mutase: B12 participates in the conversion of methylmalonyl-CoA to succinyl-CoA, linking certain fatty acid and amino acid degradation pathways into the tricarboxylic acid (TCA) cycle.

In research settings, co-formulating B12 with lipotropic agents allows investigators to explore:

• How methyl-donor and cofactor availability jointly influence homocysteine, SAM/SAH ratios, and related markers
• The relationships between B12 status, hepatic function indicators, and cellular energy metabolism
• The interplay between B12-dependent enzymatic activity and lipid-handling pathways in vitro or in vivo

Combined Formulation Models
Using LIPO-C–type preparations, researchers may design experiments to:

• Compare single-compound versus combination exposure on hepatic gene expression involved in lipid transport and methylation
• Analyze biochemical endpoints such as liver enzyme patterns, oxidative markers, phospholipid species, and methylation indices
• Study whether co-administration of B12 and lipotropic agents influences recovery or adaptation in models of metabolic or dietary stress

These experiments are intended to clarify biochemical mechanisms only and are not configured to support claims about body composition change, detoxification, or clinical outcomes.

Q1: What is LIPO-C w/B12 used for in research?
A1: LIPO-C w/B12 is used to study lipotropic and vitamin B12–related pathways, including hepatic lipid handling, methylation processes, and general metabolic biochemistry in controlled laboratory models.

Q2: Does LIPO-C w/B12 “burn fat” or detoxify the body?
A2: In a research context, LIPO-C w/B12 is not characterized as a fat-burning or detoxification product. It is a tool for examining how specific nutrients and cofactors influence biochemical processes such as liver lipid transport and one-carbon metabolism, rather than a validated method of altering body composition or detoxifying organisms.

Q3: Why is vitamin B12 included in a lipotropic blend?
A3: Vitamin B12 is an established cofactor in one-carbon and energy metabolism. When combined with lipotropic agents, it allows researchers to assess how coordinated changes in methylation capacity and phospholipid synthesis affect hepatic and systemic biochemical markers.

Q4: Is LIPO-C w/B12 intended for human injection or weight-loss programs?
A4: No. LIPO-C w/B12 from research suppliers is labeled for laboratory use only. It is not approved or intended for human or veterinary use, weight-loss programs, or any therapeutic application.

Q5: What kinds of models typically use LIPO-C w/B12?
A5: LIPO-C w/B12 may be used in cell culture or animal models focused on liver biochemistry, methylation and homocysteine pathways, nutrient interaction studies, and metabolic profiling under controlled experimental conditions.